Joseph R. Lopez Plants, invertebrate animals, amphibians and equal reptiles have the ability to reformed lost or knocked-out body parts. In the case of lizards, for example, this is a defensive mechanism. When a predator attacks, the lizard can break off its own tail as a means of distraction. While the predator is engaged eating the tail, the lizard escapes and regenerates the body part subsequent on. Mammals can regenerate some skin and liver tissue, but our regenerative abilities stop there. Unlike lizards, which have nature to thank for their regenerative capabilities, we are dependent on scientists, physicians and the business community to develop spic-and-span technologies that will help us repair and replace knocked-out tissue. How do lizards and opposite animals regenerate tissue? Part of the answer has to do with stem cells. When an amphibian loses its tail, for example, stem cells in the spinal cord migrate into the regrowing tail and differentiate into single cell types, including muscle and cartilage. This occurs simultaneously with the growth and differentiation of cells in the tail stump. Eventually, this process results in a new, fully-functional and anatomically-correct tail. The exact reasons why mammals are so limited when it comes to regenerative potential is standing not known. However, there have been significant levels of investment into stem cell research finished the past single years in the hope of nonindustrial new technologies that will offer the ability to grow lost or knocked-out tissue, and perhaps even organs. Although there have been a number of recent breakthroughs in stem cell research, technologies that will actually regenerate hominian tissue are standing several years absent from fully future to market. In the meantime, a new market is developing for products that have the ability to interact with living tissue and in whatsoever cases promote alveolate migration and growth. While these products stop well brief of growing spic-and-span limbs and organs, they do provide some solutions for many of the problems associated with traditional surgical and treatment options. The surgical biomaterials market is currently cardinal of the largest and fastest increasing global medical markets. It encompasses a number of preoperative specialties and has reached a market capitalization of single billions dollars. The rapid growth of surgical biomaterials has to do with their capacity to reduce procedure times, recovery times and complication rates, while providing clinicians with innovative approaches to improving the equal of patient care. Medical device companies worldwide are racing to bring to market biomaterial implants and devices that are designed to help repair defects in soft tissue, skin and bones. What are biomaterials? A very broad definition of surgical biomaterials may include some substance that has the capacity to function in contact with living tissue and not be rejected by the body. This would include products ready-made from metals, alloys and polyester-based materials such as orthopedic implants, and a number of opposite products traditionally old for the reconstruction or repair of tissue. The new definition of preoperative biomaterials, however, focuses on substances and products that not only evade rejection by the body, but that can interact with live tissue. These biomaterials do the job they are meant to perform, and then are either absorbed naturally by the body finished time and eliminated by biological processes or become a permanent part of the surrounding tissue. The use of nonviable materials to repair or replace defects in the human body dates back thousands of years. embryotic civilizations such as the Egyptians, Romans and Aztecs old wood, ivory, gem stones and opposite objects to replace missing teeth and fill in boney defects more than 2,500 years ago. Since then, technological developments have led to the use of a number of different synthetics and natural materials in the hominian body. From international War I finished World War II a number of natural rubbers, celluloids, vinyl polymers and polyurethanes were old for grafts, stylized hearts and catheters. During World War II, silicon was used in Japan to enhance the breasts of prostitutes and polymethylmethacrylate (PMMA), the main component in many of today’s bone cements, was used in dental and craniofacial applications. Alloys have been used as pins and plates in the hominian body since the early nineteenth century. The use of steel and opposite alloys, which have the tendency to discolor, eventually led to the development and introduction of stainless steel and titanium, materials that are still commonly used in the production of orthopedic implants today. Biomaterials can be ready-made either from unreal compounds or earthy substances. Synthetic materials such as hydroxyapatite and tricalcium phosphate have been old for years in dental, craneo-maxilofacial and orthopedic procedures. The use of earthy substances such as human or mammal-like tissue in the manufacture of preoperative biomaterials is a more recent development. A number of years of research and development in this area have led to scientific advances in the processing of earthy tissue to remove its toxicity and improve its objective properties. Natural substances generally have involved structures that are difficult to replicate with synthetic compounds, and therefore can interact with hominian tissue in ways that synthetic products cannot. The current development of preoperative biomaterials is now resulting in a number of crossbred products that integrate both natural and synthetic substances in an effort to provide products that offer the objective benefits of some materials. Some of the benefits of biomaterials can be seen in their use in surgeries that typically use “autografts”. This is when surgeons take tissue (or bone) from cardinal part of the patient’s body and then place it in another part of their body in order to repair a defect or replace unhealthy tissue. One of the most usual procedures in which autografts are old is spinal fusion, a surgery in which one or more vertebrae of the spine are welded together with the aim of eliminating painful motion. During a spinal fusion, the surgeon makes an incision in the patient’s hip and removes a piece of bone from the pelvis, which is then implanted in the space between the vertebrae and held in place by metal fasteners. The pain and problems associated with motion are ablated over time, as the implanted boney and vertebrae grow into a single, solid bone. whatsoever of the starring disadvantages of autografts in these procedures are the additive operating time it takes the surgeon to harvest the graft, the unnecessary postoperative recovery time needed and the added pain the patient must endure at the harvest site. Synthetic or animal based biomaterial bone substitutes provide surgeons and their patients with an option that lessens time under anesthesia and cuts falling on recovery time. Collagen implants for tissue repair and augmentation is other area where biomaterials may offer sound benefits over handed-down treatments. In new years, the use of membranes ready-made from natural substances such as fat and bovine dermis or pericardium has gained in popularity with surgeons. unreal membranes made from materials such as polypropylene, polyester, silicone or polytetrafluoroethylene (PTFE) have been widely used in facial aesthetic and constructive surgery, hernia repair, neurosurgery and opposite surgical procedures. While synthetic surgical meshes have good strength characteristics, they remain in the body as permanent implants and sometimes can cause adverse reactions when the close tissue identifies these materials as extrinsic bodies. A handful of companies in Europe and the U.S. have formulated new ways of collecting and processing animal collagen to produce membranes that offer the unvarying strength characteristics as synthetic membranes, but are completely biocompatible and provide a permanent solution for the repair and augmentation of tissue. Since the structure of this collagen is so related to human tissue, once it is implanted the membrane provides the basis for cellular ingrowth and revascularization. Bone graft substitutes and collagen implants do not have the capacity to help us grow spic-and-span limbs or organs. However, they are an important step in the current developments being ready-made in the fields of tissue engineering and regenerative medicine. Progress continues to be made into stem cell research and, just same amphibians and lizards, one day spic-and-span technologies may be available to help us regenerate our bodies. In the meantime, the market for surgical biomaterials continues to evolve and new technologies are continuously future to market that have the capacity to improve the quality of life of mammals around the world. About The Author